Preferentially Increased Nitration of α-Synuclein at Tyrosine-39 in a Cellular Oxidative Model of Parkinson's Disease

被引:97
作者
Danielson, Steven R. [1 ]
Held, Jason M. [1 ]
Schilling, Birgit [1 ]
Oo, May [1 ]
Gibson, Bradford W. [1 ]
Andersen, Julie K. [1 ]
机构
[1] Buck Inst Age Res, Novato, CA 94945 USA
基金
美国国家卫生研究院;
关键词
TANDEM MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; PROTEOMIC ANALYSIS; NITRIC-OXIDE; RAT-BRAIN; COMPLEX-I; AGGREGATION; STRESS; DEATH; DEHYDROGENASE;
D O I
10.1021/ac901176t
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
alpha-Synuclein is a major component of Lewy bodies, proteinacious inclusions which are a major hallmark of Parkinson's disease (PD). Lewy bodies contain high levels of nitrated tyrosine residues as determined by antibodies specific for 3-nitrotyrosine (3NT) and via mass spectrometry (MS). We have developed a multiple reaction monitoring (MRM) mass spectrometry method to sensitively quantitate the 3NT levels of specific alpha-synuclein tyrosine residues. We found a 9-fold increase (relative to controls) in levels of 3NT at Tyr-39 of alpha-synuclein in an inducible transgenic cellular model of Parkinson's disease in which monoamine oxidase B (MAO-B) is overexpressed and which emulates several features of PD. Increased nitration of Tyr-39 on endogenous alpha-synuclein via elevations in MAO-B levels could be abrogated by the addition of deprenyl, a specific MAO-B inhibitor. The increased levels of 3NT wits selective for Tyr-39 as no significant increases in 3NT levels were detected at other tyrosine residues present in the protein (Tyr-125, Tyr-133, and Tyr-136). This is the first report of increased 3NT levels of a specific tyrosine in a PD model and the first use of MRM mass spectrometry to quantify changes in 3NT modifications at specific sites within a target protein.
引用
收藏
页码:7823 / 7828
页数:6
相关论文
共 50 条
[1]  
Ahmed N, 2003, BIOCHEM SOC T, V31, P1417
[2]   Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease [J].
Anderson, John P. ;
Walker, Donald E. ;
Goldstein, Jason M. ;
de laat, Rian ;
Banducci, Kelly ;
Caccavello, Russell J. ;
Barbour, Robin ;
Huang, Jiping ;
Kling, Kristin ;
Lee, Michael ;
Diep, Linnea ;
Keim, Pamela S. ;
Shen, Xiaofeng ;
Chataway, Tim ;
Schlossmacher, Michael G. ;
Seubert, Peter ;
Schenk, Dale ;
Sinha, Sukanto ;
Gai, Wei Ping ;
Chilcote, Tamie J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) :29739-29752
[3]   Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation Sites [J].
Atsriku, Christian ;
Britton, David J. ;
Held, Jason M. ;
Schilling, Birgit ;
Scott, Gary K. ;
Gibson, Bradford W. ;
Benz, Christopher C. ;
Baldwin, Michael A. .
MOLECULAR & CELLULAR PROTEOMICS, 2009, 8 (03) :467-480
[4]  
Baba M, 1998, AM J PATHOL, V152, P879
[5]   DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[6]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[7]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306
[8]   MONOAMINE LEVELS AND MONOAMINE-OXIDASE ACTIVITY IN DIFFERENT REGIONS OF RAT-BRAIN AS A FUNCTION OF AGE [J].
BHASKARAN, D ;
RADHA, E .
MECHANISMS OF AGEING AND DEVELOPMENT, 1983, 23 (02) :151-160
[9]   OXIDATIVE STRESS IN A CLONAL CELL-LINE OF NEURONAL ORIGIN - EFFECTS OF ANTIOXIDANT ENZYME MODULATION [J].
BUCKMAN, TD ;
SUTPHIN, MS ;
MITROVIC, B .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (06) :2046-2058
[10]   ETIOLOGY OF PARKINSONS-DISEASE [J].
CALNE, DB ;
LANGSTON, JW .
LANCET, 1983, 2 (8365) :1457-1459